Online citations, reference lists, and bibliographies.

Proton Pump Inhibitors Interfere With Zinc Absorption And Zinc Body Stores

Christopher P. Farrell, Melissa Morgan, David S. Rudolph, Austin Hwang, Nicole E. Albert, Mary Carmen Valenzano, Xuexuan Wang, Giancarlo Mercogliano, James M Mullin
Published 2011 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Background Proton pump inhibitors (PPIs) cause a sharp elevation of gastro-duodenal luminal pH which in turn has resulted in reports of reduced absorption of magnesium and certain other nutrients. Methods Gastroesophageal reflux disease (GERD) patients on long-term PPI therapy (> 6 months) or healthy test subjects (not on any acid preventive or neutralizing medication) were administered oral doses of zinc gluconate (26.2 mg zinc, twice daily) for 14 days followed by 5 cc venous blood samples. Plasma was analyzed for total zinc content by atomic absorption spectrophotometry. Baseline plasma and red blood cell zinc levels were also measured in these two groups when not taking any zinc supplementation. Results Plasma zinc levels of healthy controls increased by 126% during the period of zinc supplementation compared to only a 37% increase for individuals on long-term PPI therapy. On their normal diet (with no zinc supplementation), PPI-users had a 28% lower plasma zinc level than healthy controls (P < 0.005). Conclusions PPI use dramatically reduces supplemental zinc uptake and can result in decreased zinc body stores. Certain individuals on long-term PPI therapy, such as infants being treated for colic, may be at risk for decreased systemic levels of trace metals needed for developmental, regenerative and immunological requirements.
This paper references
10.1016/j.amjmed.2009.04.014
Long-term safety concerns with proton pump inhibitors.
Tauseef Ali (2009)
10.1093/carcin/bgr004
Zinc supplementation suppresses 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis.
Louise Y. Y. Fong (2011)
Denture Cream Zinc Poisoning Consequence of Lax Chemical Regulations
MA Broeren (2010)
Vader HL, van den Wall Bake AW. Hypomagnesemia induced by several protonpump inhibitors
M A Broeren (2009)
10.1097/00010694-195611000-00018
Trace Elements in Human and Animal Nutrition
Eric J. Underwood (1971)
10.1615/JEnvironPatholToxicolOncol.v25.i3.40
The role of zinc in life: a review.
S. Frassinetti (2006)
10.1093/jn/131.9.2288
Exchangeable zinc pool masses and turnover are maintained in healthy men with low zinc intakes.
Kathryn Pinna (2001)
10.1093/ajcn/64.3.375
Does poor zinc nutriture retard skeletal growth and mineralization in adolescents?
Janet C King (1996)
10.1097/00005176-200210000-00024
Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition.
S. Rerksuppaphol (2002)
10.3949/ccjm.77a.10087
Proton pump inhibitor side effects and drug interactions: Much ado about nothing?
Ryan D. Madanick (2011)
10.1016/S0304-3835(99)00191-3
Dietary zinc deficiency enhances esophageal cell proliferation and N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumor incidence in C57BL/6 mouse.
Louise Y. Y. Fong (1999)
10.1186/1471-2431-10-41
Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study
Vasundhara Tolia (2010)
10.7326/0003-4819-151-10-200911170-00016
Hypomagnesemia induced by several proton-pump inhibitors.
Maarten A. C. Broeren (2009)
10.1111/j.1572-0241.2007.01275.x
Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression
J. Leonard (2007)
IMS Health Reports U.S. Prescription Sales Grew 5.1 Percent in 2009, to $300.3 Billion
G. Gatyas (2010)
Prescription Sales Grew 5.1 Percent in 2009, to $300.3 Billion
G Gatyas (2010)
10.1038/ajg.2009.45
Effect of Proton Pump Inhibitors on Vitamins and Iron
Kenneth E. L. McColl (2009)
10.1079/PNS19910005
Assessment of zinc status.
R P Thompson (1991)
10.1016/j.amjmed.2005.02.007
Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial.
M. B. O'Connell (2005)
10.1055/s-2001-10709
Oral zinc therapy in patients with supposed mild zinc deficiency--a critical review.
Michael Hocke (2001)
Zinc.In. Trace elements in human and animal nutrition
CC HambidgeKM (1986)
10.1001/archinternmed.2010.94
Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.
S. Gray (2010)
10.1001/jama.292.16.1955
Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
R. Laheij (2004)
Zinc absorption and achlorhydria.
Brittmarie Sandström (1989)
10.1093/ajcn/43.2.288
Zinc requirements and zinc intakes of breast-fed infants.
Nancy F. Krebs (1986)
10.1001/jama.296.24.2947
Long-term proton pump inhibitor therapy and risk of hip fracture.
Yu-Xiao Yang (2006)
10.2105/AJPH.47.4_Pt_1.496-a
Trace Elements in Human and Animal Nutrition
Arthur H. Bryan (1957)
10.3390/ijerph7041342
The Essential Toxin: Impact of Zinc on Human Health
Laura Marie Plum (2010)
10.2174/157488411794941296
Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy.
Claudio Romano (2011)
10.1136/gut.2006.108613
Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis
C. Hutchinson (2007)



This paper is referenced by
10.3390/nu11010208
Lactobacillus reuteri DSM 17938 Protects against Gastric Damage Induced by Ethanol Administration in Mice: Role of TRPV1/Substance P Axis
Ana P Oliveira (2019)
10.4291/wjgp.v5.i4.496
Zinc and gastrointestinal disease.
Sonja M. Skrovanek (2014)
10.1136/inp.m1413
Supporting the intoxicated patient: toxicants affecting the haematological and renal systems
Karen Humm (2020)
10.1038/clpt.2012.182
Drug interactions produced by proton pump inhibitors: not simply a pH effect.
James M Mullin (2013)
10.20452/pamw.15101
Effect of chronic proton pump inhibitor therapy on complete blood count parameters and selected trace elements - pilot study.
Olga Kaczmarczyk (2019)
10.3390/pharmaceutics10010036
Evidence of Drug–Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update
Emily S Mohn (2018)
10.4155/tde.13.151
Drug delivery of zinc to Barrett's metaplasia by oral administration to Barrett's esophagus patients.
Mary Carmen Valenzano (2014)
10.1007/978-1-4614-8503-2_20-1
Dietary and Nutritional Aspects of Zinc in Critically Ill Adult Patients
Beth Y. Besecker (2014)
10.3389/fonc.2020.01293
Zinc Deficiency in Men Over 50 and Its Implications in Prostate Disorders
Ann Katrin Sauer (2020)
10.1038/clpt.2012.200
Response to "Physiologically based pharmacokinetic modeling at the extremes of age".
O. Della Casa Alberighi (2013)
10.1016/j.addr.2018.09.005
Micromotors for drug delivery in vivo: The road ahead
S. Srivastava (2019)
10.3390/nu7053783
Oral Zinc Supplementation Reduces the Erythropoietin Responsiveness Index in Patients on Hemodialysis
Hiroki Kobayashi (2015)
10.3390/nu11010150
Zinc Nutritional Status in Patients with Cystic Fibrosis
Marlene Fabiola Escobedo Monge (2019)
10.1007/s00424-016-1889-3
Secretagogue-dependent and -independent transport of zinc hydration forms in rat parietal cells
Florentina Sophie Ferstl (2016)
10.1136/bcr-2012-007774
Unexpected hypozincaemia in a patient with discharging empyema that proved resistant to replacement therapy
Lynn Rowbottom (2013)
10.1371/journal.pone.0076522
Dietary Zinc Deficiency Exaggerates Ethanol-Induced Liver Injury in Mice: Involvement of Intrahepatic and Extrahepatic Factors
W. Zhong (2013)
Semantic Scholar Logo Some data provided by SemanticScholar